The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients

The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients

Aim of the Study. The administration of ursodeoxycholic acid (UDCA) as monotherapy or in combination with lactulose for the treatment of the patients with nonalcoholic steatohepatitis (NASH) has been studied insufficiently. The aim was to assess the impact of the 90-day therapy with Ursoliv® drug (2...

Full description

Saved in:
Bibliographic Details
Main Authors: I. V. Mayev, Yu. A. Kucheryavyy, S. V. Morozov, M. G. Saidullayeva, M. L. Akhtayeva, N. Yu. Stukova, E. A. Krasnyakova
Format: Article
Language:Russian
Published: Gastro LLC 2013-03-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
nonalcoholic steatohepatitis
lactulose
ursodeoxycholic acid
ursoliv®
ursosan®
Online Access:https://www.gastro-j.ru/jour/article/view/1184
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items